세계의 진단용 방사성 동위원소 시장 보고서(2025년)

Diagnostic radioisotopes are radioactive isotopes employed in nuclear medicine for diagnosing and monitoring diverse medical conditions. They rely on their radioactive decay characteristics to emit radiation, detected by specialized imaging tools, enabling healthcare providers to acquire detailed internal body structure images and evaluate their function.

The primary diagnostic radioisotopes include technetium-99m, thallium-201, gallium-67, iodine-123, fluorodeoxyglucose (FDG), rubidium-82, and others. Technetium-99m is extensively used in medical imaging due to its advantageous nuclear properties and wide accessibility. Imaging techniques include single photon emission computed tomography (SPECT), positron emission tomography (PET), and beta emitters, employed across various fields such as oncology and cardiology.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The diagnostic radioisotopes research report is one of a series of new reports from The Business Research Company that provides diagnostic radioisotopes market statistics, including the diagnostic radioisotopes industry's global market size, regional shares, competitors with a diagnostic radioisotopes market share, detailed diagnostic radioisotopes market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic radioisotopes industry. This diagnostic radioisotopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The diagnostic radioisotopes market size has grown strongly in recent years. It will grow from $5.54 billion in 2024 to $6.08 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to the discovery of radioactivity, the introduction of technetium-99m, clinical applications and research, cold war era and nuclear research, and emergence of positron emission tomography.

The diagnostic radioisotopes market size is expected to see strong growth in the next few years. It will grow to $8.62 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to emerging radioisotope production methods, expanded clinical applications, patient-centered care and safety, point-of-care imaging and environmental sustainability and green chemistry. Major trends in the forecast period include hybrid imaging techniques, theranostics, molecular imaging techniques, the use of cyclotrons or generators, and safety and radiation protection.

The forecast of 9.1% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. nuclear medicine by raising costs for technetium-99m and other critical radioisotopes imported from Canada and Belgium, potentially compromising imaging accuracy and increasing oncology and cardiology scan costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing burden of cancer is expected to drive the expansion of the diagnostic radioisotopes market. Cancer is a disease characterized by the uncontrolled division of abnormal cells that damage surrounding tissue. The increasing prevalence of cancer is attributed to various factors, including lifestyle choices such as smoking, obesity, lack of physical activity, exposure to carcinogens, genetic factors, and environmental influences. Radioisotopes play a crucial role in cancer management by providing accurate diagnosis, enabling targeted treatments, and facilitating effective monitoring of cancer progression or response to therapy. For example, in May 2024, the National Cancer Institute, a US-based government agency focused on cancer research and training, projected that by 2040, the global number of new cancer cases per year will reach 29.9 million, with 15.3 million cancer-related deaths. As a result, the rising burden of cancer is driving the growth of the diagnostic radioisotopes market.

Key players in the diagnostic radioisotopes market are focused on advancing radiopharmaceutical technology to enhance diagnostic accuracy, improve patient outcomes, and expand the applications of nuclear medicine in healthcare. Advanced radiopharmaceutical technology involves the development of innovative compounds and techniques for precise imaging and targeted therapy in nuclear medicine. For example, Bracco Group, an Italy-based diagnostic imaging company, launched Blue Earth Therapeutics in March 2022, a subsidiary dedicated to advancing next-generation therapeutic radiopharmaceutical technology, initially targeting prostate cancer with plans for further expansion into other oncology areas.

In April 2024, Telix Pharmaceuticals Limited, an Australia-based biotechnology company, acquired ARTMS to strengthen its supply chain and manufacturing capabilities. This acquisition aims to leverage ARTMS' expertise in cyclotron-based isotope production to enhance market position and meet the growing demand for diagnostic and therapeutic isotopes. ARTMS, headquartered in Canada, specializes in radioisotope technology and is a leading provider of diagnostic radioisotopes.

Major companies operating in the diagnostic radioisotopes market are Cardinal Health Inc., Sumitomo Heavy Industries Ltd., BWX Technologies Inc., Lantheus Holdings, Curium Pharma, Clarity Pharmaceuticals, Bracco Diagnostic Inc., Ion Beam Applications S.A., Nordion Inc., Eckert & Ziegler AG, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, Global Medical Solutions Ltd., Isotopia Molecular Imaging Ltd., Cyclopharm Limited, Trasis NV, Orano Med LLC, ARTMS Inc., Radiomedix Inc., Coqu RadioPharmaceuticals Corp., IsoTherapeutics Group LLC

North America was the largest region in the diagnostic radioisotopes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diagnostic radioisotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diagnostic radioisotopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diagnostic radioisotopes market consists of revenues earned by entities by providing services such as radiopharmacy services, imaging services, radioisotope production and supply, diagnostic procedures, and theranostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic radioisotopes market also includes sales of products including Indium-111, Xenon-133, Molybdenum-99, and Phosphorus-32. Values in this market are 'factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diagnostic Radioisotopes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diagnostic radioisotopes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diagnostic radioisotopes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostic radioisotopes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Radioisotope: Technetium-99m; Thallium-201; Gallium-67; Iodine-123; FluoroDeoxyGlucose (FDG); Rubidium-82; Other Radioisotopes
• 2) By Imaging Modality: Single Photon Emission Computed Tomography (SPECT); Positron Emission Tomography (PET); Beta Emitters
• 3) By Application: Oncology; Cardiology; Other Applications
• 4) By End User: Hospitals; Specialty Clinics; Diagnostic Centers; Academic And Research Institutes; Other End Users
• Subsegments:
• 1) By Technetium-99m: Diagnostic Imaging; Cardiac Imaging; Oncology Imaging; Bone Scans; Renal Scans
• 2) By Thallium-201: Cardiac Imaging; Myocardial Perfusion Imaging; Stress Tests
• 3) By Gallium-67: Oncology Imaging (Lymphoma, Tumors); Inflammatory Disease Imaging; Infection Imaging
• 4) By Iodine-123: Thyroid Imaging; Neurological Imaging (Parkinson's Disease); Cardiac Imaging
• 5) By FluoroDeoxyGlucose (FDG): Positron Emission Tomography (PET) Imaging; Cancer Diagnosis And Staging; Neurological Imaging; Cardiac Imaging
• 6) By Rubidium-82: Cardiac PET Imaging; Myocardial Perfusion Imaging; Coronary Artery Disease Diagnosis
• 7) By Other Radioisotopes: Strontium-89 (Bone Pain Palliation); Iodine-131 (Thyroid Cancer Treatment); Samarium-153 (Bone Pain Palliation); Yttrium-90 (Cancer Treatment)
• Companies Mentioned: Cardinal Health Inc.; Sumitomo Heavy Industries Ltd.; BWX Technologies Inc.; Lantheus Holdings; Curium Pharma; Clarity Pharmaceuticals; Bracco Diagnostic Inc.; Ion Beam Applications S.A.; Nordion Inc.; Eckert & Ziegler AG; NorthStar Medical Radioisotopes LLC; NTP Radioisotopes SOC Ltd; Global Medical Solutions Ltd.; Isotopia Molecular Imaging Ltd.; Cyclopharm Limited; Trasis NV; Orano Med LLC; ARTMS Inc.; Radiomedix Inc.; Coqu RadioPharmaceuticals Corp.; IsoTherapeutics Group LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diagnostic Radioisotopes market Characteristics

3. Diagnostic Radioisotopes market Trends And Strategies

4. Diagnostic Radioisotopes market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Diagnostic Radioisotopes Growth Analysis And Strategic Analysis Framework

• 5.1. Global Diagnostic Radioisotopes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Diagnostic Radioisotopes market Growth Rate Analysis
• 5.4. Global Diagnostic Radioisotopes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Diagnostic Radioisotopes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Diagnostic Radioisotopes Total Addressable Market (TAM)

6. Diagnostic Radioisotopes market Segmentation

• 6.1. Global Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Technetium-99m
• Thallium-201
• Gallium-67
• Iodine-123
• FluoroDeoxyGlucose (FDG)
• Rubidium-82
• Other Radioisotopes
• 6.2. Global Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Photon Emission Computed Tomography (SPECT)
• Positron Emission Tomography (PET)
• Beta Emitters
• 6.3. Global Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiology
• Other Applications
• 6.4. Global Diagnostic Radioisotopes market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Academic And Research Institutes
• Other End Users
• 6.5. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Technetium-99m, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Imaging
• Cardiac Imaging
• Oncology Imaging
• Bone Scans
• Renal Scans
• 6.6. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Thallium-201, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Imaging
• Myocardial Perfusion Imaging
• Stress Tests
• 6.7. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Gallium-67, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology Imaging (Lymphoma, Tumors)
• Inflammatory Disease Imaging
• Infection Imaging
• 6.8. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Iodine-123, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thyroid Imaging
• Neurological Imaging (Parkinson's Disease)
• Cardiac Imaging
• 6.9. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of FluoroDeoxyGlucose (FDG), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Positron Emission Tomography (PET) Imaging
• Cancer Diagnosis And Staging
• Neurological Imaging
• Cardiac Imaging
• 6.10. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Rubidium-82, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac PET Imaging
• Myocardial Perfusion Imaging
• Coronary Artery Disease Diagnosis
• 6.11. Global Diagnostic Radioisotopes Market, Sub-Segmentation Of Other Radioisotopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Strontium-89 (Bone Pain Palliation)
• Iodine-131 (Thyroid Cancer Treatment)
• Samarium-153 (Bone Pain Palliation)
• Yttrium-90 (Cancer Treatment)

7. Diagnostic Radioisotopes market Regional And Country Analysis

• 7.1. Global Diagnostic Radioisotopes market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Diagnostic Radioisotopes market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diagnostic Radioisotopes market

• 8.1. Asia-Pacific Diagnostic Radioisotopes market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diagnostic Radioisotopes market

• 9.1. China Diagnostic Radioisotopes market Overview
• 9.2. China Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diagnostic Radioisotopes market

• 10.1. India Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diagnostic Radioisotopes market

• 11.1. Japan Diagnostic Radioisotopes market Overview
• 11.2. Japan Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diagnostic Radioisotopes market

• 12.1. Australia Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diagnostic Radioisotopes market

• 13.1. Indonesia Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diagnostic Radioisotopes market

• 14.1. South Korea Diagnostic Radioisotopes market Overview
• 14.2. South Korea Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diagnostic Radioisotopes market

• 15.1. Western Europe Diagnostic Radioisotopes market Overview
• 15.2. Western Europe Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diagnostic Radioisotopes market

• 16.1. UK Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diagnostic Radioisotopes market

• 17.1. Germany Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diagnostic Radioisotopes market

• 18.1. France Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diagnostic Radioisotopes market

• 19.1. Italy Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diagnostic Radioisotopes market

• 20.1. Spain Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diagnostic Radioisotopes market

• 21.1. Eastern Europe Diagnostic Radioisotopes market Overview
• 21.2. Eastern Europe Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diagnostic Radioisotopes market

• 22.1. Russia Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diagnostic Radioisotopes market

• 23.1. North America Diagnostic Radioisotopes market Overview
• 23.2. North America Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diagnostic Radioisotopes market

• 24.1. USA Diagnostic Radioisotopes market Overview
• 24.2. USA Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diagnostic Radioisotopes market

• 25.1. Canada Diagnostic Radioisotopes market Overview
• 25.2. Canada Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diagnostic Radioisotopes market

• 26.1. South America Diagnostic Radioisotopes market Overview
• 26.2. South America Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diagnostic Radioisotopes market

• 27.1. Brazil Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diagnostic Radioisotopes market

• 28.1. Middle East Diagnostic Radioisotopes market Overview
• 28.2. Middle East Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diagnostic Radioisotopes market

• 29.1. Africa Diagnostic Radioisotopes market Overview
• 29.2. Africa Diagnostic Radioisotopes market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Diagnostic Radioisotopes market, Segmentation By Imaging Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Diagnostic Radioisotopes market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diagnostic Radioisotopes market Competitive Landscape And Company Profiles

• 30.1. Diagnostic Radioisotopes market Competitive Landscape
• 30.2. Diagnostic Radioisotopes market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sumitomo Heavy Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. BWX Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Lantheus Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Curium Pharma Overview, Products and Services, Strategy and Financial Analysis

31. Diagnostic Radioisotopes market Other Major And Innovative Companies

• 31.1. Clarity Pharmaceuticals
• 31.2. Bracco Diagnostic Inc.
• 31.3. Ion Beam Applications S.A.
• 31.4. Nordion Inc.
• 31.5. Eckert & Ziegler AG
• 31.6. NorthStar Medical Radioisotopes LLC
• 31.7. NTP Radioisotopes SOC Ltd
• 31.8. Global Medical Solutions Ltd.
• 31.9. Isotopia Molecular Imaging Ltd.
• 31.10. Cyclopharm Limited
• 31.11. Trasis NV
• 31.12. Orano Med LLC
• 31.13. ARTMS Inc.
• 31.14. Radiomedix Inc.
• 31.15. Coqu RadioPharmaceuticals Corp.

32. Global Diagnostic Radioisotopes market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diagnostic Radioisotopes market

34. Recent Developments In The Diagnostic Radioisotopes market

35. Diagnostic Radioisotopes market High Potential Countries, Segments and Strategies

• 35.1 Diagnostic Radioisotopes market In 2029 - Countries Offering Most New Opportunities
• 35.2 Diagnostic Radioisotopes market In 2029 - Segments Offering Most New Opportunities
• 35.3 Diagnostic Radioisotopes market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer